Top Markets
Coin of the day
Igene Biotechnology, Inc. Igene Biotechnology, Inc.

Igene Biotechnology, Inc.

IGNE
Pozycja w akcjach #41582
Igene Biotechnology, Inc. is dedicated to the discovery, development,... Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingredients and finished products to the nutraceutical and animal feed sectors. The company also extends its expertise through research and development services, which include enhancing microbial strains and skillfully developing and scaling up fermentation processes – from initial lab-based shake flasks to pilot plants and ultimately, commercial-sized fermentors. Furthermore, Igene provides analytical chemistry services for accurately identifying and quantifying carotenoids in food, feed, and animal tissues, notably offering verification to distinguish between wild and farm-raised salmonids. Established in 1981 and based in Columbia, Maryland, the company was originally named IGI Biotechnology, Inc. before officially adopting the name IGENE Biotechnology, Inc. in April 1986.
Cena akcji
$0.00001
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$15.65K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Igene Biotechnology, Inc. (IGNE)
Zyski dla Igene Biotechnology, Inc. (IGNE)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Igene Biotechnology, Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Igene Biotechnology, Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów